Millions of patients across the world use metered-dose inhalers (MDI) for asthma and other respiratory problems. The inhalers contain compressed gas hydrofluoroalkane (HFA) as a propellant to atomise and deliver medicine to the patient’s lungs.
But HFA is a major greenhouse gas with high global warming potential. Now British researchers say swapping MDIs with dry-powder inhalers (DPIs) can cut the risk.
DPIs, however, are more expensive than MDIs.
Approximately seven in ten inhaler prescriptions in the United Kingdom are MDIs. Now, every 10th MDI was swapped for a DPI, that could reduce carbon dioxide emission by 58 kilotonne, according to the new study published in British Medical Journal’s BMJ Open. The researchers studied National Health Service prescription data from England in 2017 and collated carbon footprint data on inhalers commonly used in England.
MDIs leave about 4 per cent of the carbon footprint of UK’s National Health Service. This could be overcome if DPIs were cheaper. The carbon footprint level ranges from 10-36 kilogramme of carbon dioxide per inhaler.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.